Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena J Silver

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learningThouis R Jones, Anne E Carpenter, Michael R Lamprecht, et al.
Cell|January 13, 2010
A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infectionSagi D Shapira, Irit Gat-Viks, Bennett O V Shum, et al.
Plos One|February 4, 2010
CK1epsilon is required for breast cancers dependent on beta-catenin activitySo Young Kim, Ian F Dunn, Ron Firestein, et al.
Cell|June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cellsClaudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom ReplacementBrian A Sparling, Hyelee Lee, Mary-Margaret Zablocki, et al.
Cancer Cell|October 6, 2009
Proteomic and genetic approaches identify Syk as an AML targetCynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.
Journal of Medicinal Chemistry|April 29, 2025
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9Matthew H Daniels, Jennifer Castro, Young-Tae Lee, et al.
Molecular Cancer Therapeutics|August 24, 2019
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant CancersHuai-Xiang Hao, Hongyun Wang, Chen Liu, et al.
Communications Biology|April 9, 2025
Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitorGordon J Lockbaum, Maureen M Lynes, Sophie A Shen, et al.
Nature Methods|June 28, 2011
A public genome-scale lentiviral expression library of human ORFsXiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2009
Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learningThouis R Jones, Anne E Carpenter, Michael R Lamprecht, et al.
Cell|January 13, 2010
A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infectionSagi D Shapira, Irit Gat-Viks, Bennett O V Shum, et al.
Plos One|February 4, 2010
CK1epsilon is required for breast cancers dependent on beta-catenin activitySo Young Kim, Ian F Dunn, Ron Firestein, et al.
Cell|June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cellsClaudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
ACS Medicinal Chemistry Letters|November 19, 2025
Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom ReplacementBrian A Sparling, Hyelee Lee, Mary-Margaret Zablocki, et al.
Cancer Cell|October 6, 2009
Proteomic and genetic approaches identify Syk as an AML targetCynthia K Hahn, Jacob E Berchuck, Kenneth N Ross, et al.
Journal of Medicinal Chemistry|April 29, 2025
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9Matthew H Daniels, Jennifer Castro, Young-Tae Lee, et al.
Molecular Cancer Therapeutics|August 24, 2019
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant CancersHuai-Xiang Hao, Hongyun Wang, Chen Liu, et al.
Communications Biology|April 9, 2025
Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitorGordon J Lockbaum, Maureen M Lynes, Sophie A Shen, et al.
Nature Methods|June 28, 2011
A public genome-scale lentiviral expression library of human ORFsXiaoping Yang, Jesse S Boehm, Xinping Yang, et al.
Pageof 3